HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Ihn Selected Research

agalactosyl IGG

4/2005Serum levels of anti-agalactosyl IgG antibodies in mixed connective tissue disease.
10/2004Rheumatoid factor isotypes and anti-agalactosyl IgG antibodies in systemic sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Ihn Research Topics

Disease

20Systemic Scleroderma (Systemic Sclerosis)
06/2012 - 01/2000
7Localized Scleroderma (Morphea)
07/2006 - 01/2000
7Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2006 - 01/2000
7Mixed Connective Tissue Disease (MCTD)
07/2005 - 02/2000
6Dermatomyositis (Dermatopolymyositis)
05/2016 - 06/2000
6Fibrosis (Cirrhosis)
11/2014 - 01/2000
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2016 - 01/2000
4Neoplasms (Cancer)
01/2019 - 06/2000
4Cicatrix (Scar)
10/2009 - 02/2000
3Extramammary Paget Disease (Paget Disease, Extramammary)
08/2020 - 09/2006
3Melanoma (Melanoma, Malignant)
12/2013 - 02/2008
2Hemangiosarcoma (Angiosarcoma)
04/2021 - 08/2017
2Neoplasm Metastasis (Metastasis)
01/2019 - 12/2013
2Lymphoma (Lymphomas)
03/2012 - 10/2009
2Dermatofibrosarcoma
04/2010 - 05/2006
2Diffuse Scleroderma (Progressive Systemic Sclerosis)
05/2007 - 06/2005
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2006 - 11/2001
2Sclerosis
05/2006 - 01/2000
2Collagen Diseases (Collagen Disease)
10/2004 - 04/2003
2Contracture
10/2004 - 02/2000
2Eosinophilic Fasciitis
08/2004 - 02/2003
2Interstitial Lung Diseases (Interstitial Lung Disease)
11/2002 - 06/2000
1Disease Progression
01/2019
1Hemangioma (Angioma)
08/2017
1Skin Diseases (Skin Disease)
05/2016
1Inflammation (Inflammations)
12/2013
1Carcinoma (Carcinomatosis)
03/2013
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2013
1Ulcerative Colitis
01/2013
1Atopic Dermatitis (Atopic Eczema)
11/2011
1Psoriasis (Pustulosis Palmaris et Plantaris)
11/2011
1Breast Neoplasms (Breast Cancer)
08/2011
1Skin Ulcer
10/2010
1Telangiectasis (Telangiectasia)
10/2009
1Calcinosis
10/2009

Drug/Important Bio-Agent (IBA)

8AntibodiesIBA
04/2005 - 01/2000
5Proteins (Proteins, Gene)FDA Link
08/2017 - 09/2001
4Carbon MonoxideIBA
10/2009 - 02/2000
4Rheumatoid FactorIBA
07/2005 - 08/2000
3Indicators and Reagents (Reagents)IBA
01/2019 - 01/2000
3CollagenIBA
11/2014 - 02/2006
3Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
05/2006 - 03/2001
3Immunoglobulin M (IgM)IBA
07/2005 - 08/2000
3Tissue Inhibitor of MetalloproteinasesIBA
08/2004 - 01/2000
3ImmunosorbentsIBA
02/2003 - 01/2000
3EnzymesIBA
02/2003 - 01/2000
3RNA (Ribonucleic Acid)IBA
05/2002 - 06/2001
3Biomarkers (Surrogate Marker)IBA
06/2001 - 04/2000
2DNA (Deoxyribonucleic Acid)IBA
04/2021 - 01/2019
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2017 - 04/2010
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
08/2017 - 04/2010
2Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2017 - 09/2006
2MucinsIBA
05/2016 - 06/2000
2Phosphotransferases (Kinase)IBA
12/2013 - 02/2008
2Immunoglobulin A (IgA)IBA
01/2013 - 10/2004
2Transforming Growth Factors (Transforming Growth Factor)IBA
06/2012 - 05/2006
2MicroRNAs (MicroRNA)IBA
01/2012 - 11/2011
2Intravenous Immunoglobulins (IVIG)FDA Link
05/2007 - 06/2005
2AntigensIBA
09/2006 - 10/2002
2Matrix Metalloproteinase 13IBA
07/2006 - 03/2006
2Transforming Growth Factor beta (TGF-beta)IBA
05/2006 - 02/2006
2agalactosyl IGGIBA
04/2005 - 10/2004
2Immunoglobulin G (IgG)IBA
10/2004 - 11/2000
2Tissue Inhibitor of Metalloproteinase-1IBA
08/2004 - 07/2002
2CD40 Ligand (CD40L)IBA
02/2003 - 02/2003
2Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
11/2002 - 06/2001
2Tissue Inhibitor of Metalloproteinase-2IBA
07/2002 - 01/2000
2RibonucleoproteinsIBA
09/2001 - 06/2001
2Interleukin-6 (Interleukin 6)IBA
03/2001 - 08/2000
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
08/2000 - 01/2000
2AutoantibodiesIBA
08/2000 - 01/2000
2SelectinsIBA
08/2000 - 01/2000
2E-SelectinIBA
08/2000 - 01/2000
1Lactate Dehydrogenase 5IBA
08/2020
1Carcinoembryonic AntigenIBA
01/2019
1Cell-Free Nucleic AcidsIBA
01/2019
1Keratin-19 (Keratin 19)IBA
01/2019
1Small Interfering RNA (siRNA)IBA
08/2017
1Molecular Chaperones (Chaperone, Molecular)IBA
08/2017
1Taxoids (Taxanes)IBA
08/2017
1STA 9090IBA
08/2017
1InterferonsIBA
05/2016
1JNK Mitogen-Activated Protein KinasesIBA
12/2013
1Protein Isoforms (Isoforms)IBA
12/2013
1ErbB Receptors (EGF Receptor)IBA
03/2013
1Infliximab (Remicade)FDA Link
01/2013
1Silver Sulfadiazine (SSD)FDA LinkGeneric
01/2012
1CyclinsIBA
11/2011
1Trastuzumab (Herceptin)FDA Link
08/2011
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
10/2010
1Vascular Endothelial Growth Factor DIBA
10/2010
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
04/2010
1Platelet-Derived Growth FactorIBA
04/2010
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
04/2010
1Collagen Type I (Type I Collagen)IBA
04/2010
1RetinoidsIBA
10/2009
1Interleukin-7 (Interleukin 7)IBA
05/2009

Therapy/Procedure

2Transplantation
10/2003 - 04/2003
1Drug Therapy (Chemotherapy)
08/2017
1Phototherapy (Light Therapy)
03/2012